MedPath

A Clinical Trial of D1+ Versus D2 Distal Gastrectomy for Stage IB & II Advanced Gastric Cancer

Phase 3
Conditions
Gastric Adenocarcinoma
Interventions
Procedure: D2 distal subtotal gastrectomy
Procedure: D1+ distal subtotal gastrectomy
Registration Number
NCT02144727
Lead Sponsor
National Cancer Center, Korea
Brief Summary

In oncological aspect, D1+ lymph node dissection would be enough for early stage gastric cancer in advanced gastric cancer (stage IB/IIA/IIB ).

Detailed Description

■ Background of Hypothesis A. JCOG (Japanese Clinical Oncology Group) 9501 Study

: Addition of aorta lymph node dissection to D2 lymph node dissection does not increase survival rate.

Wide range of operation is not always the best treatment. If invasion rate can be kept as minimal as possible while maintaining survival rate, it can lead to more secure operation while also reducing the frequency of complication after the surgery. 20 It may be advantageous for patients in terms of operation time, cost, and quality of life.

B. COACT 1001 study A previous study which compared the feasibility of lymph node dissection in open surgery and lapraroscopic surgery for advanced gastric cancer.

11p, 12a lymph node (D2) resection rate: 79.2% and 88.8% respectively in all advance gastric cancer.

11p, 12a lymph node (D2) metastasis rate: 1.9% and 2.9% respectively. Subgroup analysis 11p, 12a lymph node resection in cStage IB/IIA: 74.5-80.0% and 86.7-96.1% respectively. : 0% metastasis rate for both.

lymph node dissection in cStage IIB/IIIA: 81.1-82.3% and 87.5-89.2% respectively.: metastasis rates are 2.1% and 2.4-12.1% respectively.

Application: 11p and 12a lymph nodes, which belong in D2 lymph nodes, need to be resected in advance gastric cancer in IIB stage or higher. However, in earlier stages of advance gastric cancer, the probability of metastasis is very low; therefore, resection of D1+ lymph nodes, excluding 11p and 12a, is enough.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1880
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
D2 distal subtotal gastrectomyD2 distal subtotal gastrectomyD2 distal subtotal gastrectomy D2 includes Nos.1.3,4sb,4d,5,6,7,8a,9,11p,and 12a nodes in Japanese classification. Systemic en bloc lymph node dissection is mandatory. Resection margin should be negative for malignancy with intraoperative frozen biopsy
D1+ distal subtotal gastrectomyD1+ distal subtotal gastrectomyD1+ distal subtotal gastrectomy D1+ includes Nos.1,3,4sb,4d,5,6,7,8a,and 9 nodes in Japanese classification. Systemic en bloc lymph node dissection is mandatory. Resection margin should be negative for malignancy with intraoperative frozen biopsy
Primary Outcome Measures
NameTimeMethod
overall survival5 year

To test non-inferiority of survival of D1+ gastrectomy versus D2 gastrectomy for clinical stage I B \& II advanced gastric cancer

Secondary Outcome Measures
NameTimeMethod
Long term postoperative complicationsafter 30 days

Long term postoperative complications

Operating timeop day

Operating time

disease free survival3 year

3 year disease free survival

Overall cost for the treatmentoperation day to discharge

Overall cost for the treatment (from operative day to discharge day)

Subgroup analysis of Laparoscopic surgery versus open surgery3 year , 5 year

Subgroup analysis of Laparoscopic surgery versus open surgery in terms of 3 year relapse free survival and 5 year overall survival

Early postoperative complicationswithin 30 days

Early postoperative complications

Quality of life of the patients in terms of European quality of life questionnaire (EQ-5D)baseline, 1 week, 1month, 6 month, 1 year, 3 year

Quality of life of the patients in terms of European quality of life questionnaire (EQ-5D)

Finding biomarkers predicting lymph node metastasis and recurrence3 year

Finding biomarkers predicting lymph node metastasis and recurrence for prediction of lymph node metastasis and recurrence

Trial Locations

Locations (50)

National Cancer Center

🇰🇷

Goyang, Gyunggi-Do, Korea, Republic of

Keimyung University Dongsan Medical Center

🇰🇷

Daegu, Korea, Republic of

Konyang University Hospital

🇰🇷

Metropolitan City Daejon, Daejon, Korea, Republic of

Soon Chun Hyang University Hospital Cheonan

🇰🇷

Cheonan, Chuncheongnam-Do, Korea, Republic of

The Catholic University of Korea St. Vincent's Hospital

🇰🇷

Suwon, Gyeonggi-Do, Korea, Republic of

Dongguk University Medical Center

🇰🇷

Goyang, Gyeonggi-Do, Korea, Republic of

Kangwon National University Hospital

🇰🇷

Chuncheon, Gangwon-Do, Korea, Republic of

Dongguk University Gyeongju Hospital

🇰🇷

Gyeongju, Gyeongbuk, Korea, Republic of

Gyengsang National University Hospital

🇰🇷

Jinjoo, Gyeongsangnam-Do, Korea, Republic of

Ajou University Hospital

🇰🇷

Suwon, Gyeonggi-Do, Korea, Republic of

Korea University Ansan Hospital

🇰🇷

Ansan, Gyeonggi-Do, Korea, Republic of

Hanyang University Guri Hospital

🇰🇷

Guri, Gyeonggi-do, Korea, Republic of

Jeju National University Hospital

🇰🇷

Jeju, Jeju Special Self-Governing Province, Korea, Republic of

Chosun University Hospital

🇰🇷

Gwangju, Jellanam-Do, Korea, Republic of

Chonnam National University Hwasun Hospital

🇰🇷

Hwasun-Gun, Jellanam-Do, Korea, Republic of

Chonbuk National University Hospital

🇰🇷

Jeonju, Jellabuk-Do, Korea, Republic of

Dong-A University Hospital

🇰🇷

Busan, Korea, Republic of

Inje University Haeundae Paik Hospital

🇰🇷

Busan, Korea, Republic of

Pusan National University Hospital

🇰🇷

Busan, Korea, Republic of

Kosin University Gospel Hospital

🇰🇷

Busan, Korea, Republic of

Dongnam Inst. Of Radiological & Medical Sciences

🇰🇷

Busan, Korea, Republic of

Kyungpook National University Hospital

🇰🇷

Daegu, Korea, Republic of

Kungpook National University Hospital

🇰🇷

Daegu, Korea, Republic of

Yeungnam University Medical Center

🇰🇷

Daegu, Korea, Republic of

Daegu Catholic Univ. Medical Center

🇰🇷

Daegu, Korea, Republic of

Daegu Veterans Hospital

🇰🇷

Daegu, Korea, Republic of

Chungnam National University Hospital

🇰🇷

Daejeon, Korea, Republic of

Inha University Hospital

🇰🇷

Incheon, Korea, Republic of

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Gachon University Gill Medical Center

🇰🇷

Incheon, Korea, Republic of

The Catholic University of Korea Incheon St. Mary's Hospital

🇰🇷

Incheon, Korea, Republic of

Seoul Red Cross Hospital

🇰🇷

Seoul, Korea, Republic of

Severance Hospital

🇰🇷

Seoul, Korea, Republic of

KyungHee University Medical Center

🇰🇷

Seoul, Korea, Republic of

Kyung Hee University Hospital at Gangdong

🇰🇷

Seoul, Korea, Republic of

Hanyang University Medical Center

🇰🇷

Seoul, Korea, Republic of

The Catholic University of Korea St. Mary's Hospital

🇰🇷

Seoul, Korea, Republic of

Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

VHS Medical Center

🇰🇷

Seoul, Korea, Republic of

Korea University Anam Hospital

🇰🇷

Seoul, Korea, Republic of

Soon Chun Hyang University Hospital Seoul

🇰🇷

Seoul, Korea, Republic of

Hallym University Sacred Heart Hospital

🇰🇷

Seoul, Korea, Republic of

Korea Cancer Center Hospital

🇰🇷

Seoul, Korea, Republic of

SMG-SNU Boramae Medical Center

🇰🇷

Seoul, Korea, Republic of

Chung-Ang University Hospital

🇰🇷

Seoul, Korea, Republic of

Ewha Womans University Medical Center

🇰🇷

Seoul, Korea, Republic of

Gangnam Severance Hospital

🇰🇷

Seoul, Korea, Republic of

Asan Medical Center

🇰🇷

Seoul, Korea, Republic of

Konkuk University Medical Center

🇰🇷

Seoul, Korea, Republic of

Korea University Guro Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath